Development of Simplified in Vitro P-Glycoprotein Substrate Assay and in Silico Prediction Models To Evaluate Transport Potential of P-Glycoprotein

被引:37
|
作者
Ohashi, Rikiya [1 ,3 ]
Watanabe, Reiko [3 ]
Esaki, Tsuyoshi [3 ]
Taniguchi, Tomomi [1 ]
Torimoto-Katori, Nao [1 ]
Watanabe, Tomoko [2 ]
Ogasawara, Yuko [2 ]
Takahashi, Tsuyoshi [2 ]
Tsukimoto, Mikiko [1 ]
Mizuguchi, Kenji [3 ]
机构
[1] Mitsubishi Tanabe Pharma Corp, Discovery Technol Labs, 2-2-50 Kawagishi, Toda, Saitama 3358505, Japan
[2] Mitsubishi Tanabe Pharma Corp, SDMPK Res Labs, 2-2-50 Kawagishi, Toda, Saitama 3358505, Japan
[3] Natl Inst Biomed Innovat Hlth & Nutr, Lab Bioinformat, 7-6-8 Saito Asagi, Ibaraki, Osaka 5670085, Japan
关键词
P-glycoprotein; substrate; nonsubstrate; in vitro screening; in silico prediction; physicochemical parameters; correlation; machine learning; CANCER RESISTANCE PROTEIN; CENTRAL-NERVOUS-SYSTEM; BLOOD-BRAIN-BARRIER; DRUG DISCOVERY; EFFLUX; PENETRATION; IMPACT; PERMEABILITY; DISPOSITION; EXPRESSION;
D O I
10.1021/acs.molpharmaceut.8b01143
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
For efficient drug discovery and screening, it is necessary to simplify P-glycoprotein (P-gp) substrate assays and to provide in silico models that predict the transport potential of P-gp. In this study, we developed a simplified in vitro screening method to evaluate P-gp substrates by unidirectional membrane transport in P-gp-overexpressing cells. The unidirectional flux ratio positively correlated with parameters of the conventional bidirectional P-gp substrate assay (R-2 = 0.941) and in vivo K-p,K-brain ratio (mdr1a/1b KO/WT) in mice (R-2 = 0.800). Our in vitro P-gp substrate assay had high reproducibility and required approximately half the labor of the conventional method. We also constructed regression models to predict the value of P-gp-mediated flux and three-class classification models to predict P-gp substrate potential (low-, medium-, and high-potential) using 2397 data entries with the largest data set collected under the same experimental conditions. Most compounds in the test set fell within two- and three-fold errors in the random forest regression model (71.3 and 88.5%, respectively). Furthermore, the random forest three-class classification model showed a high balanced accuracy of 0.821 and precision of 0.761 for the lowpotential classes in the test set. We concluded that the simplified in vitro P-gp substrate assay was suitable for compound screening in the early stages of drug discovery and that the in silico regression model and three-class classification model using only chemical structure information could identify the transport potential of compounds including P-gp-mediated flux ratios. Our proposed method is expected to be a practical tool to optimize effective central nervous system (CNS) drugs, to avoid CNS side effects, and to improve intestinal absorption.
引用
收藏
页码:1851 / 1863
页数:13
相关论文
共 50 条
  • [1] An in vitro evaluation of guanfacine as a substrate for P-glycoprotein
    Gillis, Nancy K.
    Zhu, Hao-Jie
    Markowitz, John S.
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2011, 7 : 501 - 505
  • [2] In Silico Characterization of P-Glycoprotein Substrate Entrance Pathways
    Domicevica, Laura
    Paramo, Teresa
    Biggin, Philip C.
    BIOPHYSICAL JOURNAL, 2016, 110 (03) : 141A - 141A
  • [3] Mibefradil is a P-glycoprotein substrate and a potent inhibitor of both P-glycoprotein and CYP3A in vitro
    Wandel, C
    Kim, RB
    Guengerich, FP
    Wood, AJJ
    DRUG METABOLISM AND DISPOSITION, 2000, 28 (08) : 895 - 898
  • [4] Is MIBG a substrate of P-glycoprotein?
    Kiyono, Yasushi
    Yamashita, Tomoko
    Doi, Hisako
    Kuge, Yuji
    Katsura, Toshiya
    Inui, Ken-Ichi
    Saji, Hideo
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 (04) : 448 - 452
  • [5] Is MIBG a substrate of P-glycoprotein?
    Yasushi Kiyono
    Tomoko Yamashita
    Hisako Doi
    Yuji Kuge
    Toshiya Katsura
    Ken-Ichi Inui
    Hideo Saji
    European Journal of Nuclear Medicine and Molecular Imaging, 2007, 34 : 448 - 452
  • [6] Carbamazepine is not a substrate for P-glycoprotein
    Owen, A
    Pirmohamed, M
    Tettey, JN
    Morgan, P
    Chadwick, D
    Park, BK
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 51 (04) : 345 - 349
  • [7] In silico model for P-glycoprotein substrate prediction: insights from molecular dynamics and in vitro studies
    Rameshwar Prajapati
    Udghosh Singh
    Abhijeet Patil
    Kailas S. Khomane
    Pravin Bagul
    Arvind K. Bansal
    Abhay T. Sangamwar
    Journal of Computer-Aided Molecular Design, 2013, 27 : 347 - 363
  • [8] In silico model for P-glycoprotein substrate prediction: insights from molecular dynamics and in vitro studies
    Prajapati, Rameshwar
    Singh, Udghosh
    Patil, Abhijeet
    Khomane, Kailas S.
    Bagul, Pravin
    Bansal, Arvind K.
    Sangamwar, Abhay T.
    JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2013, 27 (04) : 347 - 363
  • [9] Fingerprint-based in silico models for the prediction of P-glycoprotein substrates and inhibitors
    Poongavanam, Vasanthanathan
    Haider, Norbert
    Ecker, Gerhard F.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2012, 20 (18) : 5388 - 5395
  • [10] Chalcone Derivatives as Potential Inhibitors of P-Glycoprotein and NorA: An In Silico and In Vitro Study
    Minh-Tri Le
    Dieu-Thuong Thi Trinh
    Trieu-Du Ngo
    Viet-Khoa Tran-Nguyen
    Dac-Nhan Nguyen
    Tung Hoang
    Hoang-Minh Nguyen
    Tran-Giang-Son Do
    Tan Thanh Mai
    Thanh-Dao Tran
    Khac-Minh Thai
    BIOMED RESEARCH INTERNATIONAL, 2022, 2022